330 related articles for article (PubMed ID: 17544117)
41. [Diagnosis and therapy of 186 spontaneous bacterial peritonitis patients with end-stage liver disease].
Zhou Z; Lai N; Zhang QH; Guo Y; Huang CW; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):350-2. PubMed ID: 15225430
[TBL] [Abstract][Full Text] [Related]
42. Sclerosing peritonitis and mortality after liver transplantation.
Mekeel K; Moss A; Reddy KS; Douglas D; Mulligan D
Liver Transpl; 2009 Apr; 15(4):435-9. PubMed ID: 19326414
[TBL] [Abstract][Full Text] [Related]
43. Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria.
Chang CY; Singal AK; Ganeshan SV; Schiano TD; Lookstein R; Emre S
Liver Transpl; 2007 Nov; 13(11):1532-7. PubMed ID: 17969202
[TBL] [Abstract][Full Text] [Related]
44. [TIPS or paracentesis in refractory ascites?].
Poralla T
Z Gastroenterol; 1997 Dec; 35(12):1115-8. PubMed ID: 9487644
[No Abstract] [Full Text] [Related]
45. Progress in treatment of massive ascites and hepatorenal syndrome.
Gerbes AL; Gulberg V
World J Gastroenterol; 2006 Jan; 12(4):516-9. PubMed ID: 16489662
[TBL] [Abstract][Full Text] [Related]
46. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
47. Dynamic MR perfusion measurements before and after TIPS in cirrhotic patients with refractory ascites.
Maleux G; De Keyzer F; Prinsloo J; Heye S; Nevens F; Marchal G
Acad Radiol; 2007 Nov; 14(11):1400-8. PubMed ID: 17964463
[TBL] [Abstract][Full Text] [Related]
48. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Knotek M; Rogachev B; Schrier RW
Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
[TBL] [Abstract][Full Text] [Related]
49. [Hepatorenal syndrome in patients with liver cirrhosis].
Zaza S; Bonny O; Liaudet L
Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular abnormalities in special conditions of advanced cirrhosis. The circulatory adaptative changes to specific therapeutic procedures for the management of refractory ascites.
Pozzi M; Ratti L; Redaelli E; Guidi C; Mancia G
Gastroenterol Hepatol; 2006 Apr; 29(4):263-72. PubMed ID: 16584698
[TBL] [Abstract][Full Text] [Related]
51. [Spontaneous bacterial peritonitis: new approaches to diagnostics in alcoholic liver cirrhosis].
Vinnitskaia EV
Eksp Klin Gastroenterol; 2008; (4):97-102. PubMed ID: 19145909
[No Abstract] [Full Text] [Related]
52. [New approaches to diagnostics of spontaneous bacterial peritonitis in liver cirrhosis].
Vinnitskaia EV; Osipov AG; Drozdov VN; Petrakov AV; Lazebnik LB
Eksp Klin Gastroenterol; 2008; (2):32-9. PubMed ID: 19145865
[No Abstract] [Full Text] [Related]
53. Concomitant hepatic encephalopathy and refractory ascites: successful treatment with staged embolization of two large portosystemic shunts and transjugular intrahepatic portosystemic shunt placement.
Smith JC; Black MD; Mendler MH
J Vasc Interv Radiol; 2007 Nov; 18(11):1441-6. PubMed ID: 18003997
[TBL] [Abstract][Full Text] [Related]
54. The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study.
Lata J; Marecek Z; Fejfar T; Zdenek P; Brůha R; Safka V; Hůlek P; Hejda V; Dolina J; Stehlík J; Tozzi I
Hepatogastroenterology; 2007; 54(79):1930-3. PubMed ID: 18251131
[TBL] [Abstract][Full Text] [Related]
55. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
56. Update on ascites and hepatorenal syndrome.
Gentilini P; Vizzutti F; Gentilini A; Zipoli M; Foschi M; Romanelli RG
Dig Liver Dis; 2002 Aug; 34(8):592-605. PubMed ID: 12502217
[TBL] [Abstract][Full Text] [Related]
57. Transjugular intrahepatic portosystemic shunts in liver transplant recipients.
Kim JJ; Dasika NL; Yu E; Fontana RJ
Liver Int; 2008 Feb; 28(2):240-8. PubMed ID: 18251981
[TBL] [Abstract][Full Text] [Related]
58. Pathophysiology and management of pediatric ascites.
Sabri M; Saps M; Peters JM
Curr Gastroenterol Rep; 2003 Jun; 5(3):240-6. PubMed ID: 12734047
[TBL] [Abstract][Full Text] [Related]
59. Treatment of hepatorenal syndrome.
Kiser TH; Maclaren R; Fish DN
Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
[TBL] [Abstract][Full Text] [Related]
60. Advances in critical care management of hepatic failure and insufficiency.
Han MK; Hyzy R
Crit Care Med; 2006 Sep; 34(9 Suppl):S225-31. PubMed ID: 16917427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
